DC Biosciences

A Company set up for Scientists by Scientists

History

Between 2006 and 2016 DC Biosciences Ltd. operated as Dundee Cell Products Ltd. (DCP). DCP was founded in 2006 as a spin-out of the internationally renowned School of Life Sciences of the University of Dundee by Professor Angus Lamond (Lamond Lab). Since spin-out the company has developed close interactions with researchers across a number of internationally acclaimed institution and research organisations.

In 2007 and again in 2009 the company secured equity investment funding from a syndicate of angel investors and the Scottish Co-investment Fund to finance and expand its activities. Today, DC Biosciences is recognised as a leading global player in proteomics services and molecular biology.

Brand Evolution
What we do

DC Biosciences provides pharmaceutical and biotech companies with novel technologies and proteomics services to accelerate the development of safer drugs. We are best placed to apply our knowledge and experience in a wide range of bioscience disciplines including quantitative proteomics, chemical biology, biochemistry, molecular biology, bioinformatics and cell biology to provide solutions in key areas of drug discovery and development.

We have developed a quantitative proteomics-based technology portfolio that offers solutions to preclinical activities of the drug discovery process and developed new processes for biomarker discovery and validation, drug re-profiling and repositioning.

  • Chief Executive Officer

  • Chief Scientific Officer

  • Scientific Advisor

  • Investment Directors

  • Chief Executive Officer

    Mr John Ivinson

  • Chief Scientific Officer

    Dr Francesco Rao

  • Scientific Advisor

    Professor Angus Lamond

  • Investment Directors

    Scott Carnegie, Donald Smith

  • Mr John Ivinson

  • Dr Francesco Rao

  • Professor Angus Lamond

  • Scott Carnegie, Donald Smith